Capricor Therapeutics CAPR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's accounts payable?
- Capricor Therapeutics (CAPR) reported accounts payable of $3.93M in Q1 2026.
- How has Capricor Therapeutics's accounts payable changed year-over-year?
- Capricor Therapeutics's accounts payable decreased by 25.2% year-over-year, from $5.25M to $3.93M.
- What is the long-term trend for Capricor Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), Capricor Therapeutics's accounts payable has grown at a -9.4% compound annual growth rate (CAGR), from $2.72M to $1.65M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.